It can be very scary to talk odds when discussing healthcare, especially for children. Pediatricians around the world will tell you how tricky it can be to help children fighting the same diseases as adults but not having access to the same treatments. This is can be due to many factors (fewer clinical trials for children, untested treatments for the younger age group, lack of child-friendly medications, etc.). This is why we got excited when we heard Dr. Caridad Martinez talking about a more than 90% survival rate for pediatric patients receiving a cord blood transplant for non-malignant diseases. We knew we needed to learn more! We are thrilled to welcome her as our next featured speaker on Share the Science.

In this session of Share the Science, Dr. Martinez will focus on the critical role of umbilical cord blood transplantation in curing pediatric patients with non-malignant disorders. Drawing on extensive clinical experience and published data, she will highlight survival outcomes exceeding 90% in children undergoing cord blood transplant for non-malignant diseases.

​In addition, she will also present recent North American data on severe combined immune deficiency, demonstrating that event-free and overall survival can surpass 90% when conditioning is used without serotherapy.

Finally, Dr. Martinez will discuss emerging evidence showing that careful selection of cord blood units—particularly optimizing cell dose and donor-recipient matching—can further improve outcomes to similarly high survival rates. These sessions are intended to highlight the significance of preserving cord blood units as an essential resource for curative treatments in pediatric patients.

SHARE THE SCIENCE
with
​
Janette Sampson (NHS Leeds - Clinical Nurse Specialist)
&
Colin Baker, Cord Blood Transplant Recipient 


"Cord blood answers the call:
Treating a case of myelodysplastic syndrome" 

Free webinar.  Open to the public.
​
Thursday, July 10th 1pm US Eastern Time / 12 noon Central Time

RECORDING NOW AVAILABLE
​

Both public and private cord blood banking are at a crossroads as traditional transplant continues to draw on limited public registries and the private cord blood banks continue to cater to families with specific needs. But, where are the new opportunities in these areas? How can we provide a vital medical service while still continuing to expand and educate? This is often seen as an uphill battle for both public and private cord blood banks. 

Our featured speaker, Roberto Waddington has rare insight on ways to move the industry forward and seize those opportunities for growth.  Join us he explores common questions around cord blood banking, such as: 

• Are medical and scientific excellence and sustainable profitability two opposing objectives? 
• Where do we draw the line between marketing and ethics?

In this webinar, we'll explore what public and private cord blood banks like you need to know about the growth challenges surrounding cord blood banking and how to prepare. You'll get the opportunity to see evidence on the clinical utility of cord blood and how it can improve the lives of patients and medical professionals around the globe.